Ignite Creation Date:
2025-12-25 @ 1:46 AM
Ignite Modification Date:
2025-12-31 @ 11:49 AM
Study NCT ID:
NCT01001494
Status:
COMPLETED
Last Update Posted:
2017-01-04
First Post:
2009-10-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Aclidinium Bromide at Two Dose Levels Versus Placebo Administered in Chronic Obstructive Pulmonary Disease (COPD) Patients
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-10
Start Date Type:
None
Primary Completion Date:
2010-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-11
Completion Date Type:
ACTUAL
First Submit Date:
2009-10-22
First Submit QC Date:
None
Study First Post Date:
2009-10-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-08-14
Results First Submit QC Date:
None
Results First Post Date:
2012-09-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-11-16
Last Update Post Date:
2017-01-04
Last Update Post Date Type:
ESTIMATED